- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Alaska Oncology and Hematology Anchorage, Alaska, United States
- City of Hope - Phoenix Goodyear, Arizona, United States
- Marin Cancer Care Inc Greenbrae, California, United States
- Hoag Memorial Hospital Newport Beach, California, United States
Clinical trial condition
KRAS G12C Lung Cancer
Explore clinical trials studying KRAS G12C Lung Cancer. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
KRAS G12C Lung Cancer trial results
Not Yet Recruiting
Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in Resectable Stage IIA-IIIB KRAS G12C-Mutant NSCLC (GIVEN Study)
NCT07472478
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
NCT06936644
- Conditions
- KRAS G12C Lung Cancer
- Locations
-
Not specified
Active, Not Recruiting
A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer
NCT06497556
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Banner Health MD Anderson AZ Gilbert, Arizona, United States
- Los Angeles Cancer Network Los Angeles, California, United States
- UCLA Hematology / Oncology Clinic Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States